First Premounted, Balloon-Expandable Stent Cleared for Iliac Arteries


March 11, 2010

March 11, 2010 – The FDA has cleared the first low-profile, premounted, balloon-expandable stent system for use in treating iliac artery disease.

The Express LD Iliac Stent is designed to be highly deliverable, and balance strength, flexibility and conformability.

“Boston Scientific’s Express LD Iliac Stent incorporates a flexible stent design and is engineered for improved deployment accuracy, two critical treatment components,” said Barry Katzen, M.D., Baptist Cardiac and Vascular Institute in Miami. “With an approved iliac indication, the Express LD Stent offers physicians a less-invasive alternative to surgery for our patients suffering from iliac artery disease.”

The approval adds another device to Boston’s treatment options for peripheral artery disease, which includes the Carotid WALLSTENT Endoprosthesis for carotid artery disease and the Express SD Stent for renal artery disease.

The Express LD Iliac Stent has CE mark approval in Europe and is currently approved for iliac use in a number of international markets.

“I have found that the benefits of a balloon-expandable stent like the Express LD Iliac Stent can be extremely important when working in atherosclerotic iliac lesions,” said Luc Stockx, M.D., of Limburgs Vaatcentrum Ziekenhuis, Belgium. “Deployment accuracy and radial strength can play crucial roles in these types of procedures, and the Express LD Stent is designed to deliver both.”

For more information: